Soleus Capital Management, L.P. Jasper Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.93 $659,400 - $1.46 Million	1,570,000 Added 18.91%	9,870,980 $7.8 Million
Q3 2023 Nov 14, 2023	BUY	$0.68 - $1.54 $357,000 - $808,500	525,000 Added 6.75%	8,300,980 $5.81 Million
Q2 2023 Aug 14, 2023	BUY	$1.19 - $1.79 $381,990 - $574,590	321,000 Added 4.31%	7,775,980 $10.7 Million
Q1 2023 May 15, 2023	BUY	$1.48 - $2.74 $11 Million - $20.4 Million	7,454,980 New	7,454,980 $13.5 Million

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $806M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.